Literature DB >> 17663424

TNFSF15 is an ethnic-specific IBD gene.

Yoana Picornell1, Ling Mei, Kent Taylor, Huiying Yang, Stephan R Targan, Jerome I Rotter.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is a clinically and, likely, genetically heterogeneous group of disorders. A recent report suggests that genetic variations in the TNFSF15 gene contribute to the susceptibility of IBD in both Japanese and Caucasian populations. The aim was to confirm the association between TNFSF15 high- and low-risk haplotypes and IBD in a Caucasian population.
METHODS: Five single-nucleotide polymorphisms (SNPs) that comprise the 2 common haplotypes were genotyped in 599 Caucasian patients with Crohn's disease (CD), 382 Caucasian patients with ulcerative colitis (UC), and 230 ethnically matched healthy controls, including both Jews and non-Jews.
RESULTS: The previously reported 'risk' haplotype was not associated with CD or UC (88.2% in CD cases versus 88.3% in controls, P = 0.96; 88.1% in UC cases versus 88.3% in controls, P = 0.78). We did, however, observe an increased frequency of the "protective" haplotype in non-Jewish controls for both CD and UC (38.8% CD cases versus 50% controls, P = 0.01; 37.3% UC cases versus 50% controls, P = 0.01) with no such effect observed in the Jewish samples. There was an interactive effect between ethnicity and the protective haplotype in CD (P = 0.04).
CONCLUSIONS: We observed a protective haplotype, consisting of the minor alleles for all 5 markers, to have a higher frequency in the non-Jewish controls than in CD and UC. Of further interest, the haplotype frequency was in the opposite direction in our Jewish case-control panels (both CD and UC), leading us to conclude 1) that TNFSF15 is indeed an IBD susceptibility gene, and 2) the disease susceptibility is ethnic-specific.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17663424      PMCID: PMC2552994          DOI: 10.1002/ibd.20223

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  50 in total

1.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

2.  Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.

Authors:  Konstantinos A Papadakis; Daocheng Zhu; John L Prehn; Carol Landers; Armine Avanesyan; Gina Lafkas; Stephan R Targan
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

3.  Small bowel barium studies in Crohn's disease.

Authors:  C Gasche; E Schober; K Turetschek
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

4.  Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.

Authors:  E A Vasiliauskas; S E Plevy; C J Landers; S W Binder; D M Ferguson; H Yang; J I Rotter; A Vidrich; S R Targan
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations.

Authors:  E A Trachtenberg; H Yang; E Hayes; M Vinson; C Lin; S R Targan; D Tyan; H Erlich; J I Rotter
Journal:  Hum Immunol       Date:  2000-03       Impact factor: 2.850

6.  TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

Authors:  Thi Sau Migone; Jun Zhang; Xia Luo; Li Zhuang; Cecil Chen; Bugen Hu; June S Hong; James W Perry; Su Fang Chen; Joe X H Zhou; Yun Hee Cho; Stephen Ullrich; Palanisamy Kanakaraj; Jeffrey Carrell; Ernest Boyd; Henrik S Olsen; Gang Hu; Laurie Pukac; Ding Liu; Jian Ni; Sunghee Kim; Reiner Gentz; Ping Feng; Paul A Moore; Steve M Ruben; Ping Wei
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

7.  A genome-wide search identifies potential new susceptibility loci for Crohn's disease.

Authors:  Y Ma; J D Ohmen; Z Li; L G Bentley; C McElree; S Pressman; S R Targan; N Fischel-Ghodsian; J I Rotter; H Yang
Journal:  Inflamm Bowel Dis       Date:  1999-11       Impact factor: 5.325

8.  Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.

Authors:  Giorgos Bamias; Charles Martin; Marco Marini; Sharon Hoang; Margarita Mishina; William G Ross; Muhammadreza A Sachedina; Charles M Friel; James Mize; Stephen J Bickston; Theresa T Pizarro; Ping Wei; Fabio Cominelli
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

9.  Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.

Authors:  John L Prehn; Shahab Mehdizadeh; Carol J Landers; Xia Luo; Stephanie C Cha; Ping Wei; Stephan R Targan
Journal:  Clin Immunol       Date:  2004-07       Impact factor: 3.969

10.  Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease.

Authors:  H Yang; D K Vora; S R Targan; H Toyoda; A L Beaudet; J I Rotter
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

View more
  35 in total

1.  Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.

Authors:  Robert Barrett; Xiaolan Zhang; Hon Wai Koon; Michelle Vu; Jyh-Yau Chang; Nicole Yeager; Mary Ann Nguyen; Kathrin S Michelsen; Dror Berel; Charalabos Pothoulakis; Stephan R Targan; David Q Shih
Journal:  Am J Pathol       Date:  2011-12-02       Impact factor: 4.307

2.  TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.

Authors:  Hidetoshi Takedatsu; Kathrin S Michelsen; Bo Wei; Carol J Landers; Lisa S Thomas; Deepti Dhall; Jonathan Braun; Stephan R Targan
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

Review 3.  Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.

Authors:  Noam Jacob; Stephan R Targan; David Q Shih
Journal:  United European Gastroenterol J       Date:  2016-05-10       Impact factor: 4.623

4.  Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease.

Authors:  Dermot P B McGovern; Jerome I Rotter; Ling Mei; Talin Haritunians; Carol Landers; Carrie Derkowski; Deb Dutridge; Marla Dubinsky; Andy Ippoliti; Eric Vasiliauskas; Emebet Mengesha; Lily King; Sheila Pressman; Stephan R Targan; Kent D Taylor
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

5.  Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans.

Authors:  Suk-Kyun Yang; Myunghee Hong; Hyunchul Choi; Wanting Zhao; Yusun Jung; Talin Haritunians; Byong Duk Ye; Kyung-Jo Kim; Sang Hyoung Park; Inchul Lee; Won Ho Kim; Jae Hee Cheon; Young-Ho Kim; Byung Ik Jang; Hyun-Soo Kim; Jai Hyun Choi; Ja Seol Koo; Ji Hyun Lee; Sung-Ae Jung; Hyoung Doo Shin; Daehee Kang; Hee-Shang Youn; Kent D Taylor; Jerome I Rotter; Jianjun Liu; Dermot P B McGovern; Kyuyoung Song
Journal:  Inflamm Bowel Dis       Date:  2015-01       Impact factor: 5.325

Review 6.  Insights into IBD Pathogenesis.

Authors:  David Q Shih; Stephan R Targan
Journal:  Curr Gastroenterol Rep       Date:  2009-12

7.  Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells.

Authors:  David Q Shih; Lola Y Kwan; Valerie Chavez; Offer Cohavy; Rivkah Gonsky; Elmer Y Chang; Christopher Chang; Charles O Elson; Stephan R Targan
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

8.  IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.

Authors:  Kathrin S Michelsen; Lisa S Thomas; Kent D Taylor; Qi T Yu; Ling Mei; Carol J Landers; Carrie Derkowski; Dermot P B McGovern; Jerome I Rotter; Stephan R Targan
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

9.  Fine-scale detection of population-specific linkage disequilibrium using haplotype entropy in the human genome.

Authors:  Hideaki Mizuno; Gurinder Atwal; Haijian Wang; Arnold J Levine; Alexei Vazquez
Journal:  BMC Genet       Date:  2010-04-23       Impact factor: 2.797

Review 10.  Genetics of Inflammatory Bowel Diseases.

Authors:  Dermot P B McGovern; Subra Kugathasan; Judy H Cho
Journal:  Gastroenterology       Date:  2015-08-07       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.